Active

Agilus Diagnostics Limited

Agilus Diagnostics Limited IPO Details

Listing Date

-

Bid Price

₹0 - ₹0

Lot Size

0 Shares

Minimum Investment

Issue Size

₹0 Cr

Key Dates to Track

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

-

tick

Offer End Date

-

tick

Allotment Date

-

tick

Refund Initiation

-

tick

Demat Transfer

-

tick

Listing Date

-

Agilus Diagnostics Limited Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 0% 0%
Public Group 100% 100%

Agilus Diagnostics Limited IPO Reservation

QIB Shares Offered 0 (0%)
NII (HNI) Shares Offered 0 (0%)
Retail Shares Offered 0 (0%)
Anchor Investor Shares Offered 0 (0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

Agilus Diagnostics Limited IPO Lot Size

Application Lots Shares Amount
Retail (Min) [-] [-] ₹[-]
Retail (Max) [-] [-] ₹[-]
S HNI (Min) [-] [-] ₹[-]
S HNI (Max) [-] [-] ₹[-]
B HNI (MIN) [-] [-] ₹[-]

Agilus Diagnostics Limited IPO registrar

KFin Techologies Ltd
Phone Number +91 40 6716 2222 / 18003094001
Email Id adl.ipo@kfintech.com
Website www.kfintech.com

Agilus Diagnostics Limited IPO Lead Manager

1. ICICI Securities Ltd

2. Axis Capital Ltd

3. Citigroup Global Markets India Pvt Ltd

Agilus Diagnostics Limited Financial Information

March 31, 2024 March 31, 2023 March 31, 2022
Net Worth ₹1,987.74 Cr ₹1,945.58 Cr ₹1,866.15 Cr
Reserves and Surplus ₹1,909.31 Cr ₹1,867.15 Cr ₹1,787.73 Cr
Total Borrowing ₹3.74 Cr ₹2.83 Cr ₹2.25 Cr

Strength of Agilus Diagnostics Limited

  • Experienced pan-India diagnostics service provider with a diversified presence and a growing network that is well positioned to capitalize on the expected growth in the Indian diagnostics industry.
  • Comprehensive test offerings providing one stop solution for diagnostic requirements.
  • Advanced information technology platform supported by integrated systems enabling customer-centric initiatives.
  • Well-balanced B2C and B2B revenue mix.
  • Quality network of accredited laboratories supported by R&D capabilities focused on genomics and nextgeneration diagnostics.
  • Strong parentage and experienced management team with significant industry experience.

Risks Involved

  • The company recently changed its brand which led to certain legal proceedings that are currently pending before the Delhi High Court. Any unfavorable outcome may have an adverse effect on its business, reputation, results of operations and financial condition.
  • Any failure to establish its new brand may adversely affect customer confidence in the company services or its inability to maintain and enhance its brand and reputation or any negative publicity and allegations, may have an adverse impact on its business, reputation, results of operations and financial condition.
  • Its trade mark applications in relation to its new brand, "Agilus Diagnostics" and "Agilus" are not yet registered, and some have been objected/ opposed by other parties. Any inability to obtain registration or otherwise protect its intellectual property rights, or any exposure to misappropriation and infringement claims by third parties, could have an adverse effect on its business, reputation, financial condition and results of operations.
  • Its Promoter, Fortis Healthcare Limited, is subject to certain regulatory and statutory proceedings, including an appeal pending before the Securities Appellate Tribunal and an ongoing investigation by the Serious Fraud Investigation Office for certain alleged improper transactions and non-compliance with applicable laws and regulations including the Companies Act. Any prolonged proceedings or adverse outcome of such proceedings in the future may have an adverse impact on its business and reputation.
  • There are outstanding litigation against the Company, Promoter, Directors, Group Companies and Subsidiaries. An adverse outcome in any of these proceedings may affect its reputation and standing and impact its future business and could have a material adverse effect on its business, results of operations, financial condition and cash flows.
  • The company is liable to protect its patients' personal information and any failure to protect such information, could materially and adversely affect its business, results of operations and financial condition.
  • The company is subject to various operational, reputational, medical and legal claims, regulatory actions or other liabilities arising from the provision of healthcare services and may be subject to liabilities arising from claims of malpractice and medical negligence which could adversely affect its business, results of operations and financial condition.
  • Its industry is highly regulated and requires it to obtain, renew and maintain statutory and regulatory permits, accreditations, licenses and comply with applicable safety, health, environmental, labor and other governmental regulations. Any regulatory changes or violations of such rules and regulations may adversely affect its business, results of operations and financial condition.
  • The company currently avail tax benefits and are entitled to certain incentives. Any change in these benefits and incentives applicable to it or a delay in disbursement of benefits under such schemes may affect its results of operations.
  • The company has entered into a master service agreement with its Promoter and certain other letters/ agreements with its Promoter and its affiliates in respect of providing certain laboratory management services to them and are dependent on them for a portion of its revenues. Any non-performance, non-renewal/ revision, substantial change in the agreed rates or termination of such agreements may adversely affect its business, results of operations and financial condition.
stock
Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Bidding Period
10th Jun 2026 - 6th Jun 2026
Price Range
₹62.0 - 66.0
IPO Size
₹35,00,00,000
  • All
  • MainBoard
  • SME
Bidding Period
11th Jun 2026 - 6th Jun 2026
Price Range
₹120.0 - 127.0
IPO Size
₹70,38,00,000
Bidding Period
12th Jun 2026 - 6th Jun 2026
Price Range
₹98.0 - 103.0
IPO Size
₹54,27,00,000
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
GENXAI ANALYTICS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
5th Jun 2026 - 6th Jun 2026
Price Range
₹110.0 - 116.0
IPO Size
₹54,84,00,000
HEXAGON NUTRITION LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
5th Jun 2026 - 6th Jun 2026
Price Range
₹42.0 - 45.0
IPO Size
₹1,39,00,00,000
UHM VACATION LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
4th Jun 2026 - 6th Jun 2026
Price Range
₹157.0 - 166.0
IPO Size
₹36,02,00,000
VAHH CHEMICALS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
4th Jun 2026 - 6th Jun 2026
Price Range
₹61.0 - 61.0
IPO Size
₹13,00,00,000
Bidding Period
3rd Jun 2026 - 6th Jun 2026
Price Range
₹182.0 - 192.0
IPO Size
₹6,31,00,00,000
LIOTECH INDUSTRIES LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
1st Jun 2026 - 6th Jun 2026
Price Range
₹321.0 - 321.0
IPO Size
₹36,00,00,000
MERRITRONIX LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
1st Jun 2026 - 6th Jun 2026
Price Range
₹141.0 - 149.0
IPO Size
₹70,00,00,000
SMR JEWELS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
26th May 2026 - 6th Jun 2026
Price Range
₹125.0 - 128.0
IPO Size
₹12,54,00,000
AUREATE TRADDE LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
29th May 2026 - 6th Jun 2026
Price Range
₹70.0 - 70.0
IPO Size
₹27,00,00,000
Bidding Period
26th May 2026 - 5th May 2026
Price Range
₹59.0 - 63.0
IPO Size
₹18,00,00,000
HARIKANTA OVERSEAS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
20th May 2026 - 5th May 2026
Price Range
₹86.0 - 91.0
IPO Size
₹24,00,00,000
YAASHVI JEWELLERS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
25th May 2026 - 5th May 2026
Price Range
₹83.0 - 83.0
IPO Size
₹44,00,00,000
M R MANIVENI FOODS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
22nd May 2026 - 5th May 2026
Price Range
₹51.0 - 52.0
IPO Size
₹27,00,00,000
QLINE BIOTECH LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
21st May 2026 - 5th May 2026
Price Range
₹326.0 - 343.0
IPO Size
₹2,14,00,00,000
AUTOFURNISH LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
21st May 2026 - 5th May 2026
Price Range
₹41.0 - 41.0
IPO Size
₹15,00,00,000
Bidding Period
21st May 2026 - 5th May 2026
Price Range
₹132.0 - 139.0
IPO Size
₹52,00,00,000
Bidding Period
20th May 2026 - 5th May 2026
Price Range
₹73.0 - 77.0
IPO Size
₹38,00,00,000
Bidding Period
19th May 2026 - 5th May 2026
Price Range
₹61.0 - 63.0
IPO Size
₹50,15,00,000
NFP SAMPOORNA FOODS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
18th May 2026 - 5th May 2026
Price Range
₹52.0 - 55.0
IPO Size
₹25,00,00,000
RFBL FLEXI PACK LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
12th May 2026 - 5th May 2026
Price Range
₹47.0 - 50.0
IPO Size
₹35,00,00,000
  • All
  • MainBoard
  • SME
MERRITRONIX LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
149.00
Listing Day Close
297.25(99.33%)
SMR JEWELS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
128.00
Listing Day Close
103.05(-19.53%)
AUREATE TRADDE LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
70.00
Listing Day Close
66.50(-4.29%)
Issue Prize
63.00
Listing Day Close
60.57(-3.17%)
HARIKANTA OVERSEAS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
91.00
Listing Day Close
75.77(-16.48%)
YAASHVI JEWELLERS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
83.00
Listing Day Close
87.05(4.82%)
M R MANIVENI FOODS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
52.00
Listing Day Close
41.13(-21.15%)
QLINE BIOTECH LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
343.00
Listing Day Close
474.60(38.48%)
AUTOFURNISH LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
41.00
Listing Day Close
45.15(9.76%)
Issue Prize
139.00
Listing Day Close
115.80(-16.55%)
Issue Prize
77.00
Listing Day Close
124.00(61.04%)
Issue Prize
63.00
Listing Day Close
72.75(15.87%)
NFP SAMPOORNA FOODS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
55.00
Listing Day Close
51.80(-5.45%)
RFBL FLEXI PACK LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
50.00
Listing Day Close
55.10(10.00%)
Issue Prize
43.00
Listing Day Close
56.77(32.56%)
SIMCA ADVERTISING LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
183.00
Listing Day Close
163.80(-10.38%)
BAGMANE PRIME OFFICE REIT IPO
icon
SME IPO
Early Access
Issue Prize
100.00
Listing Day Close
103.66(4.00%)
RECODE STUDIOS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
158.00
Listing Day Close
223.75(41.77%)
Issue Prize
98.00
Listing Day Close
82.30(-16.33%)
Issue Prize
171.00
Listing Day Close
208.40(21.64%)

Frequently Asked Questions

What is Agilus Diagnostics Limited IPO?

Answer Field

Agilus Diagnostics Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on .

When Agilus Diagnostics Limited IPO will open?

Answer Field

The Agilus Diagnostics Limited IPO opens on [-] and closes on [-].

What is the lot size of Agilus Diagnostics Limited?

Answer Field

Agilus Diagnostics Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Agilus Diagnostics Limited IPO?

Answer Field

You can apply in Agilus Diagnostics Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

  • Login to Bajaj Broking account App/Website & click on IPO
  • Enter the number of lots and price at which you wish to apply.
  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
  • You will receive a mandate notification to block funds in your UPI app.
  • Approve the mandate request on your UPI and funds will be blocked.

When is Agilus Diagnostics Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Agilus Diagnostics Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Agilus Diagnostics Limited IPO listing date?

Answer Field

The Agilus Diagnostics Limited listing date is [-].

Who is the registrar of Agilus Diagnostics Limited IPO?

Answer Field

The registrar of Agilus Diagnostics Limited IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

ICICI Securities Ltd,Axis Capital Ltd,Citigroup Global Markets India Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Agilus Diagnostics Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Agilus Diagnostics Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Agilus Diagnostics Limited IPO?

Answer Field

To apply for Agilus Diagnostics Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Agilus Diagnostics Limited?

Answer Field

The price of each Agilus Diagnostics Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Agilus Diagnostics Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|